男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Negotiators work to bring down nation's prescriptions

Public paying dramatically less for therapeutic drugs thanks to bulk-buy scheme

By WANG XIAOYU | China Daily | Updated: 2025-02-06 08:47
Share
Share - WeChat
A worker checks capsules on a production line in Liuyang, Hunan province, in June. CHEN SIHAN/XINHUA

Du Wentao, chairman of Yichang Humanwell Pharmaceutical, said during an interview with state broadcaster China Central Television that it has spent five years and over 70 million yuan in researching the drug.

"So far, our drugs have only been introduced to less than 20 percent of relevant hospitals and many parents have to travel far to larger hospitals to obtain the drug," he said. "Getting on the list means that grassroots coverage for the drug will be improved and more child patients can access effective treatment."

Wu Jing, deputy dean of Tianjin University's School of Pharmaceutical Science and Technology, said, "The speedy action related to boosting access to the drug has demonstrated the government's attention to the rare disease patient community."

Even though the market price of domestic Clobazam per tablet is only 3 yuan, Wu said that the medicine is usually delivered along with other drugs and the total costs constitute a heavy burden on some families.

"The price reduction could range from a few percent to over 90 percent because the principle is not purely chasing after steep cuts, but a pursuit of the most reasonable price," Wu said. "All negotiated prices will be tested against economic barometers that evaluate clinical value."

Huang, the official from the National Healthcare Security Administration, said that during price negotiations in late October, a total of 28 drugs failed to secure a deal. The reason was that their anticipated prices had exceeded the bottom-line price by a giant margin, and some drugmakers were unwilling to reduce their prices to a level lower than the international average.

Authorities were looking for the lowest price compared to the United States, the United Kingdom, Japan and other developed countries, which have a much higher GDP per capita compared to China. It is reasonable to ask for a lower price than these markets considering China's large population, Huang said.

|<< Previous 1 2 3 4 5 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 大悟县| 尖扎县| 吕梁市| 达孜县| 泸定县| 乌恰县| 家居| 平乐县| 黑龙江省| 牡丹江市| 蓬溪县| 启东市| 莎车县| 屏东市| 鄱阳县| 田阳县| 军事| 横峰县| 于都县| 永德县| 时尚| 吉安市| 突泉县| 阿拉善左旗| 云安县| 白水县| 垣曲县| 太谷县| 南开区| 斗六市| 天祝| 繁峙县| 江山市| 政和县| 景德镇市| 高碑店市| 孟连| 拜泉县| 海原县| 玛曲县| 六盘水市|